Purpose: The goal of this study was to estimate pre- and post-gadolinium-enhanced high-spatial resolution susceptibility-weighted imaging (SWI) in patients with brain neoplasms.
Materials and methods: A total of 17 patients (8 women, 9 men) with brain neoplasms participated in this study. In addition to conventional magnetic resonance imaging, pre- and post-gadolinium-enhanced SWI was performed. The contrast-to-noise ratio (CNR) and major diameters of the brain tumor were measured for quantitative analyses, and intratumoral susceptibility signal intensity (ITSS) was graded for semiquantitative analysis.
Results: Both bright and dark enhancement were observed at the pathological lesion on postcontrast SWI. Some postcontrast SWI results suggested leakage of contrast material due to breakdown of the blood-brain barrier. There were no statistical differences (Student's t-test) between postcontrast SWI and three-dimensional (3D) T1-weighted images regarding the major diameters of the brain tumors. CNR of postcontrast 3D T1-weighted images was statistically superior to that of postcontrast SW images (P < 0.01, Wilcoxon signed-rank test). Malignant tumors tended to have a higher ITSS score.
Conclusion: SWI clearly visualized the architecture of brain neoplasms. This imaging technique may be useful for evaluating tumor characterization in clinical use.